前列腺素E2通过诱导miR675-5p下调p53促进结直肠癌转移
该研究探讨前列腺素E2(PGE2)促进结直肠癌(CRC)进展的机制。通过对LS174T细胞进行miRNA测序,发现PGE2通过AKT/NF-κB/β-catenin通路上调Myc进而增加miR675-5p表达;miR675-5p结合TP53 mRNA的3'非翻译区抑制p53翻译。PGE2处理的LS174T细胞在NOD-scidIL-2Rg-/-小鼠中形成更多肝和肺转移;miR675-5p或其前体H19表达与COX-1/COX-2表达及患者较短生存相关。
要点
- PGE2通过AKT/NF-κB/β-catenin-Myc轴上调miR675-5p。
- miR675-5p靶向TP53 mRNA 3'UTR抑制p53蛋白翻译。
- PGE2增强CRC细胞侵袭及小鼠肝肺转移能力。
核心结论
- PGE2通过上调miR675-5p抑制p53表达,增强结直肠癌细胞的侵袭和肝肺转移能力。
研究设计与样本
- 体外培养LS174T结直肠癌细胞,给予PGE2或对照,进行miRNA测序比较表达谱。
- 利用siRNA或基因组编辑敲低特定miRNA或蛋白,进行免疫印迹、qPCR、染色体免疫沉淀、细胞侵袭和荧光素酶报告基因实验。
- NOD-scidIL-2Rg-/-小鼠注射LS174T细胞,定量原发肿瘤生长及肝肺转移数量,并进行组织学分析。
- 利用公共数据库分析基因表达模式与患者预后的相关性。
主要发现
- miR675-5p是PGE2处理CRC细胞后上调最显著的miRNA。
- PGE2通过激活AKT、NF-κB和β-catenin上调Myc,进而增加miR675-5p表达。
- PGE2增强培养CRC细胞的侵袭活性。
- PGE2处理的LS174T细胞在小鼠中形成比对照更多的肝和肺转移。
- miR675-5p结合TP53 mRNA的3'非翻译区,导致p53蛋白丢失。
临床怎么用
- 靶向PGE2或其下游miR675-5p/p53轴可能成为结直肠癌治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Prostaglandin E2 (PGE2) promotes colorectal tumor formation and progression by unknown mechanisms. We sought to identify microRNAs (miRNAs) that might mediate the effects of PGE2 on colorectal cancer (CRC) development. METHODS: We incubated LS174T colorectal cancer cells with PGE2 or without (control) and used miRNA-sequencing technology to compare expression patterns of miRNAs. We knocked down levels of specific miRNAs or proteins in cells using small interfering RNAs or genome editing. Cells were analyzed by immunoblot, quantitative polymerase chain reaction, chromosome immunoprecipitation, cell invasion, and luciferase reporter assays; we measured gene expression, binding activity, cell migration and invasion, and transcriptional activity of transcription factors. NOD-scidIL-2Rg-/- mice were given injections of LS174T cells, and growth of primary tumors and numbers of liver and lung metastases were quantified and analyzed by histology. We used public databases to identify correlations in gene expression pattern with patient outcomes. RESULTS: We identified miRNA 675-5p (miR675-5p) as the miRNA most highly up-regulated by incubation of colorectal cancer cells with PGE2. PGE2 increased expression of miR675-5p by activating expression of Myc, via activation of protein kinase B, also known as (AKT), nuclear factor κB, and β-catenin. PGE2 increased the invasive activities of cultured CRC cells. LS174T cells incubated with PGE2 formed more liver and lung metastases in mice than control LS174T cells. We identified a 3' untranslated region in the TP53 messenger RNA that bound miR675-5p; binding resulted in loss of the p53 protein. Expression of miR675-5p or its precursor RNA, H19, correlated with expression of cyclooxygenase-1 and cyclooxygenase-2 and shorter survival times of patients with CRC. CONCLUSIONS: We found that treatment of mice with PGE2 increased CRC cells invasive activity and ability to form liver and lung metastases. PGE2 down-regulates expression of p53 by increasing expression of miR675-5p, which binds to and prevents translation of TP53 messenger RNA. These findings provide insight into the mechanisms by which PGE2 promotes tumor development and progression. Strategies to target PGE2 might be developed for treatment of CRC.
引用
- Cen B, Lang JD, Du Y, et al. Prostaglandin E2 Induces miR675-5p to Promote Colorectal Tumor Metastasis via Modulation of p53 Expression. Gastroenterology. 2019. PMID: 31734182. doi:10.1053/j.gastro.2019.11.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。